MPC Therapeutics
Plan-les-ouates
About MPC Therapeutics
MPC Therapeutics is a biotechnology company. For patients with cancer and degenerative disorders, the company is presently concentrating on creating life-altering medications. They develop a class of compounds with the ability to modify mitochondrial processes in order to alter the conductivity of the cell and prevent the growth of diseases by using their medicinal chemistry and mitochondrial biology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.8M
- Funding stage: Seed
- Last round: Debt Financing (Nov 2023)
- Website: mpc-therapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/mpc-therapeutics-64135 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.